How ubiquitous transcription factors (TFs) coordinate temporal inputs from broadly expressed epigenetic factors to control cell fate remains poorly understood. Here, we uncover a molecular relationship between p53, an abundant embryonic TF, and WDR5, an essential member of the MLL chromatin modifying complex, that regulates mouse embryonic stem cell fate. Wild-type Wdr5 or transient Wdr5 knockout promotes a distinct pattern of global chromatin accessibility and spurs neuroectodermal differentiation through an RbBP5-dependent process in which WDR5 binds to, and activates transcription of, neural genes. Wdr5 rescue after its prolonged inhibition targets WDR5 to mesoderm lineage-specifying genes, stimulating differentiation toward mesoderm fates in a p53-dependent fashion. Finally, we identify a direct interaction between This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). WDR5 and p53 that enables their co-recruitment to, and regulation of, genes known to control cell proliferation and fate. Our results unmask p53-dependent mechanisms that temporally integrate epigenetic WDR5 inputs to drive neuroectoderm and mesoderm differentiation from pluripotent cells.
transcription and, thus, WDR5 contributes to regulation of gene expression (Dou et al., 2006; Rao and Dou, 2015) .
WDR5 interacts with OCT4, CTCF, or lncRNA to facilitate induced pluripotent stem cell reprogramming and maintains ESC identity (Ang et al., 2011; Yang et al., 2014) . Wdr5 haploin-sufficiency in fetal mesoderm triggers somitogenesis defects and WDR5 overexpression accelerates Wnt-mediated osteoblast differentiation (Gori et al., 2006; Vilhais-Neto et al., 2017) . WDR5 point mutations are linked to congenital heart defects (Zaidi et al., 2013; Zhu et al., 2017) and disrupted speech development (Eising et al., 2019) in humans. Still, the role of WDR5 in cell fate determination immediately following exit from pluripotency remains enigmatic.
Like WDR5, p53 is enriched in ESCs and decreases during differentiation (Lin et al., 2005) . p53 is ubiquitous in the mouse embryo up to day 11 (Lin et al., 2005; Schmid et al., 1991; Rogel et al., 1985) . Its abundance and enhanced stability in ESCs suggest roles that may contrast from its function in somatic cells, in which p53 is degraded rapidly by MDM2, and regulates the DNA damage response (Haupt et al., 1997; Sabapathy et al., 1997; Giaccia and Kastan, 1998) . Moreover, p53 hyperactivation occurs in several developmental syndromes (e.g., CHARGE and others) that feature neuroectoderm (NE) defects .
Here, we identify a regulatory role for WDR5 on the activity of p53 during key ESC cell fate transitions. Molecularly, we found that WDR5 regulates p53 stability and directly interacts with p53 during ESC specification. Intact Wdr5 activity or brief Wdr5 inhibition leads to a distinct chromatin landscape in which WDR5 directly targets NE genes and favors transcription of NE lineage-specifying genes and differentiation of NE organoids. In contrast, prolonged Wdr5 inhibition causes dysregulated ribosomal protein (RP) gene expression and enhanced p53 stability, which leads to p53 activation. Increased p53 activity promotes mesoderm specification, as well as a global chromatin accessibility landscape that is permissive for mesoderm differentiation. Wdr5 rescue redirects WDR5 to mesoderm lineage-identity genes, which promotes differentiation toward contractile cardiogenic and hematopoietic mesoderm fates in a p53-dependent manner. This WDR5-p53 cell fate pathway offers a previously unrecognized example of how a broadly expressed epigenetic factor and embryonically abundant protein coordinate ESC lineage specification and differentiation in a time-dependent manner.
which contain GFP reporter knocked in to the endogenous NE-specific Rax/Rx promoter; these lines efficiently generate Rx + NE organoids via serum-free embryoid body (EB)-like aggregates with quick reaggregation (SFEBq) culture (Assawachananont et al., 2014; . We derived four independently targeted, hWDR5 Dox ;mWdr5 KO (WDR5 Dox ;Wdr5 KO ) Rx-GFP mESC lines (Figures S1A-S1F). Interestingly, while Wdr5 transcripts decreased during NE differentiation, Wdr5 mRNA was expressed in both Rx + and Rx − EBs ( Figure S1A ). hWDR5 expression did not alter Rx + NE induction in wild-type (WT) ESCs (Figures S1B and S1C). In Wdr5 KO EBs, Dox removal decreased hWDR5 ( Figure S1G ) and global histone marks H3K4Me2/3, but not H3K4Me1 ( Figure S1H) , consistent with the histone-modifying function of WDR5 (Wysocka et al., 2005) .
Next, we assessed the role of WDR5 in NE differentiation. Impaired cell proliferation and Rx + NE differentiation of Wdr5 KO EBs was rescued by Dox-induced WDR5 in a dosedependent manner (Figures 1A and 1B) . To test whether interaction of known WDR5 cofactors (Wysocka et al., 2005) , MLL1 and RbBP5, with WDR5 is essential for NE differentiation, we expressed FLAG-tagged WT or mutant WDR5 into WDR5 Dox ;Wdr5 KO ESCs ( Figure S11) . Surprisingly, Wdr5 KO EBs expressing WDR5-MLL1 mutants (WDR5 F133Y or WDR5 I305V ) proliferated and differentiated to Rx + NE normally (Figures 1C and 1D) . Wdr5 KO EBs constitutively expressing WDR5-RbBP5-binding mutants WDR5 N225A , WDR5 L240K , WDR5 V268E , or WDR5 Q289E showed reduced NE differentiation (Figures 1C and 1D) and Rx mRNA ( Figure 1E ). Defective NE differentiation of WDR5-RbBP5-binding mutants, except for WDR5 Q289E , could not be fully rescued with WT WDR5 induced by Dox at 12 h following NE differentiation (T12h; Figures 1C-1F ). We next derived dexamethasone (Dex) and Dox double-inducible Wdr5 KO ESCs (Figures S2A and S2B) , in order to express WDR5-RbBP5 interaction mutants at similar levels. Dex treatment induced translocation of cytoplasmic WT WDR5 to the nucleus in Wdr5 KO ESCs, which maintained ESC pluripotency and self-renewal (data not shown). Both Dex-induced nuclear WT-WDR5 and Dox-inducible WT-WDR5 supported NE proliferation in Wdr5 KO EBs in monolayer and suspension-based NE differentiation culture conditions (Figures S2C and S2D) . However, Dox-induced expression of WDR5-RbBP5-binding mutants, expressed at similar levels ( Figure S2B ) in Wdr5 KO EBs, showed defective NE differentiation (Figures 1G, S2C, and S2D) . Together, we find specific interaction surfaces of WDR5 and RbBP5 are required for Rx + NE differentiation.
Timing of WDR5 Expression in ESCs Mediates an NE versus Mesoderm Fate Decision
To determine whether WDR5 exerts time-dependent effects on lineage-specific ESC differentiation, we rescued Wdr5 KO EBs with Dox-inducible WDR5 at consecutive 12-h intervals ( Figure 2A ). Induction of WDR5 from T12-24h after differentiation (hereafter termed "early void," "early rescue," or brief inhibition [of WDR5]) maintained EB proliferation and stimulated NE differentiation ( Figures S3A and S3B ). However, WDR5 induction at T36-48h after differentiation (hereafter named as "extended void," "late rescue," or prolonged inhibition) maintained Wdr5 KO EB growth but impaired NE formation. Unlike WT or early-void groups, virtually all extended-void EBs spontaneously contracted by days 8-9, suggesting cardiogenic mesoderm (MES) differentiation. Timecourse qRT-PCR analysis showed induced cardiomyocyte-lineage transcripts in three independent WDR5 Dox ;Wdr5 KO ESC lines in extended-void conditions such as Ncad (Honda et al., 2006), cTnT, αMHC, βMHC, and Myocd mRNA (Figures 2B and S3C-S3E) .
Cardiogenic-lineage-specific proteins such as intracellular N-cadherin, cTnT (CT3), and myosin heavy chain (MF20) were also present ( Figure 2C ). In contrast, WT and early-void groups showed induction of NE-specific Rx mRNA ( Figures 2B and S3D) , Moreover, Ncadherin exhibited NE-specific apical localization in WT or Wdr5 KO EBs with Doxinducible WDR5 in early-void groups ( Figure 2C ) . Time-course western blotting analyses confirmed expression of exogenous WDR5 protein in Wdr5 knockout (KO) EBs with Dox-inducible early and extended voids ( Figure S3F ). Cardiogenic MES differentiation was both WDR5 time ( Figure 2D ) and dose dependent ( Figure 2E ), indicating that MES induction is specific to WDR5 and not simply a "default" pathway for ESC differentiation. Further, generation of cardiogenic MES was genetically driven by Wdr5 and independent of external cues specific to SFEBq differentiation such as retinoic acid receptor antagonism, or specific lots of matrigel or KO serum replacement ( Figure 2F ; data not shown). Induction of the MES master transcription factor (TF) T/Brachyury in Wdr5 KO EBs with extended voids ( Figure 2F ) prompted us to examine whether other MES lineages may form in these conditions. When Wdr5 KO EBs with extended voids were seeded into methylcellulose-based differentiation medium at day 6 or 9 for secondary hematopoietic differentiation ( Figure 2G , upper panel), colony-forming units of granulocyte-macrophage progenitor cells (CFU-GM, CFU-G, and CFU-M) arose, which were not observed in Wdr5 KO EBs with early voids ( Figure 2G , lower panel; Figures S3G and S3H ). These data demonstrate that an extended void in Wdr5 KO EBs stimulates ESCs toward cardiogenic and hematopoietic MES fates. This time-dependent ESC fate transition to MES occurs in SFEBq conditions, which does not contain the exogenous cytokines or fetal calf serum usually required for ESC-derived MES differentiation Eiraku et al., 2008 . These findings demonstrate that the length of time of Wdr5 inhibition, followed by subsequent WDR5 rescue, determines whether ESCs differentiate toward NE versus MESspecific lineages. Since continuous and early voids (T12h) stimulate NE differentiation, and an extended void (T36-48h) promotes cardiogenic or hematopoietic MES formation, we further conclude that EB day 2 (T48h) defines a crucial period of lineage specification during which differentiating ESCs make an NE versus MES fate decision.
The WDR5-RbBP5 Interaction Surface Regulates Mesoderm-Related Transcription
We next asked whether the WDR5-RbBP5 interaction surface regulates cardiogenic MES induction. Wdr5 KO EBs expressing constitutive WDR5 N225A, L240K or V268E mutants showed ~50û300-fold induction of cTnT mRNA ( Figure 2H , left panel). This pro-cardiogenic MES induction effect was inhibited by concomitant rescue of WT WDR5 at T12h ( Figure 2H , left panel). However, WDR5 Q289E had similar capacity as WT WDR5 to repress cTnT mRNA upregulation in Wdr5 KO EBs ( Figure 2H , right panel). Thus, while the WDR5-RbBP5 interaction promotes NE fates ( Figure 1C ), it only partially restrains transcription of cardiogenic MES-related genes.
WDR5 Regulates Overlapping and Distinct Direct Target Genes in Divergent Cell Lineages
To identify molecular targets for WDR5 in Rx + NE and cardiogenic MES lineages, we performed RNA sequencing (RNA-seq) from EB day 6 RNA isolated from four groups: WT, Wdr5 KO , Wdr5 KO with early (T12h Rescue ), or extended (T48h Rescue ) void. The majority of differentially expressed transcripts arose, and overlapped (75%-80%; Figure 3A ), in WT versus T48h Rescue (2,758), and T12h Rescue versus T48 Rescue (2,937) groups ( Figure S4A ), compared to those of WT versus T12h Rescue groups (593; Figure S4A ). These data indicate that transcriptomes of WT and T12h Rescue groups were comparable and harbored RNA profiles distinct from T48h Rescue and Wdr5 KO groups ( Figure S4B ). Gene Ontology (GO) themes in the T12h Rescue group included NE development, while those of the T48h Rescue group emphasized MES specification ( Figure 3B ). RNA-seq analysis indicated that trophectoderm markers (Cdx2 and Gata3) and endoderm markers (Gata4 and Gata6) were upregulated in T48h Rescue group (data not shown). Time-course qRT-PCR analysis showed that Cdx2 and Gata3 mRNA were transiently upregulated in T36-48h Rescue groups during differentiation, to a greater degree than in the WT and T12h Rescue groups ( Figure 3C ; data not shown), consistent with a previous report (Ang et al., 2011) . However, the lack of concomitant endoderm-specific Foxa2 upregulation suggested that Gata4 upregulation suggests formation of lateral mesoderm rather than endoderm in T36-48h Rescue groups ( Figure 3C ) (Rojas et al., 2005) .
To define direct target genes of WDR5 in NE and MES lineages, we performed HA-WDR5 chromatin immunoprecipitation sequencing (ChIP-seq) in Wdr5 KO EBs with T12h Rescue and T48h Rescue at EB day 6. We found that in both groups, WDR5 bound to intergenic, intron, and promoter regions ( Figure S4C ). Using peak centers of HA-WDR5-bound targets in the T12h Rescue or T48h Rescue group ( Figure 3D ) as references, we found that WDR5 bound both overlapping and distinct targets. In both NE organoids and MES-enriched EBs, we identified distinct de novo and known WDR5 target DNA motifs, including consensus sites shared with c-MYC, consistent with a previous report ( Figure S4D ) . Integration of ChIP-seq with RNA-seq datasets revealed WDR5-bound targets that were associated with >2-fold differential gene expression ( Figure S4E ). Such WDR5 direct target genes in the T12h Rescue group (123 genes: 76 and 47 genes down-and upregulated, respectively) included NE-related genes such as Sox2, Nestin, Sfrp2, and others (Figures 3E and S4E) . In the T48h Rescue group (45 genes: 25 and 20 genes down-and upregulated, respectively), these included MES-associated genes such as Pabpc4l, Nr3c1, Egln3, and others ( Figures 3E and S4E ). 22 direct WDR5 target genes (10 and 12 genes down-and upregulated, respectively) overlapped in both the NE and MES lineages, including Efcab12, Esrrb, Brn2, and 8 RP genes such as Rpl5 and Rpl37 ( Figure S4E ). These data show that WDR5 targets both overlapping and distinct genes in NE organoids and MES-enriched EBs.
WDR5 Regulates Target Gene Expression with Dynamic Chromatin Accessibility during ESC Lineage Specification
WDR5 is a core member of the MLL chromatin-modifying complex and is essential for H3K4me3 formation ( Figure S1H ) (Dou et al., 2006; Rao and Dou, 2015) . Having established that WDR5 regulates differentiation of Rx + NE and cardiogenic MES lineages at EB day 6, we sought to understand chromatin-related events that precede the formation of these distinct lineages, in WT EBs and immediately before T48h Rescue in Wdr5 KO EBs, during the lineage specification period (EB day 2). RNA-seq analyses at EB day 2 revealed that ~60% of differentially expressed genes were downregulated in Wdr5 KO EBs ( Figure  4A ). We used CUT&RUN (cleavage under targets and release using nuclease sequencing) to define the genomic targets of WDR5 and H3K4me3 in WT and Wdr5 KO EBs at day 2 ( Figure 4B ) (Meers et al., 2019) . H3K4me3 at WT WDR5-bound chromatin targets were reduced in Wdr5 KO EBs ( Figure 4C ). Genome-wide integration of WDR5-bound peaks from CUT&RUN with transcripts from RNA-seq data elucidated direct WDR5 target genes during EB day 2 lineage specification ( Figure 4D ). In Wdr5 KO EBs, we detected 33 WDR5 direct target genes. Of 33 genes, 20 were downregulated including Rpl29 and E2f3, which are genes essential for NE proliferation or differentiation while 13 genes were upregulated including Nodal, which is required for MES specification. Interestingly, differentially expressed transcripts of WDR5 direct target genes in day 2 WT and Wdr5 KO EBs overlapped with those of day 6 WT and Wdr5 KO EBs ( Figure S5A ). As Wdr5 deletion led to both down-and upregulated direct target genes, we posited that WDR5-mediated canonical (transcriptional activation) and non-canonical H3K4me3 (transcriptional repression) chromatin mechanisms contribute to WDR5-mediated target gene regulation . To this end, we performed ATAC-seq to determine whether WDR5 regulates "open and closed" chromatin accessibility regions at NE and MES lineage-identity genes. Genome-wide analyses revealed that genes with loss of H3K4me3 mark correlated, to some extent, with reduced chromatin accessibility in day 2 Wdr5 KO EBs ( Figure 4F ). We observed increased ("open") chromatin accessibility at the NE-specific gene Rx transcription start site (TSS) region as early as EB day 4 in WT and T12h Rescue groups, indicating proper NE specification ( Figure 4E ). In contrast, chromatin accessibility at the Rx TSS region remained inaccessible ("closed") during the day 2-6 differentiation period in Wdr5 KO EBs with the T48h Rescue group. For the MES-specific gene cTnT/Tnnt2, opening peaks were observed at its TSS in Wdr5 KO EBs with T48h Rescue until EB day 6 differentiation, but not in WT and T12h Rescue groups ( Figure 4E ).
We next sought to gain insights into WDR5-dependent, chromatin accessibility during lineage specification (EB day 2). Decreased chromatin accessibility in Wdr5 KO EBs at day 2 was associated with NE-pathways ( Figures 4G and S5B ) and motif analysis of those closing peaks correlated with the NE master regulator SOX1 ( Figure S5C ). Increased chromatin accessibility in Wdr5 KO EBs at day 2 was associated with Hippo, Wnt, and p53-signaling pathways (Figures 4G and S5B) and motif analysis of those open peaks correlated with transcription factor NF-YB and YY1 ( Figure S5C ). Indeed, activation of p53 and Wnt signaling pathways, and the transcription factor YY1, have been previously reported to promote MES differentiation (Wang et al., 2017; Gregoire et al., 2017) . Hyperactivation of the Hippo pathway and overexpression of YAP impairs neural differentiation in mESCs (Lian et al., 2010) , which is consistent with defective NE differentiation in Wdr5 KO EBs. Collectively, these data show that prolonged Wdr5 inactivation triggers alterations in chromatin accessibility and target gene expression that are permissive for MES differentiation and repressive for NE induction.
p53 Signaling Contributes to the NE versus Cardiogenic MES Cell Fate Decision
p53 signaling emerged as a common theme in GO analyses of opening peaks in ATAC-seq ( Figure 4G ) and of RNA-seq in Wdr5 KO EBs at days 2 and 6, respectively (Figures 4G and S5D) . Indeed, the p53 direct target gene Cdkn1a mRNA in Wdr5 KO EBs was upregulated at days 2 and 3 ( Figure 6C ). To test whether p53 activation regulates Wdr5-mediated NE and MES fate choice, we edited p53 via CRISPR-Cas9 to derive WDR5 Dox ;Wdr5 KO Rx-GFP ESC lines ( Figures S6A and S6B ). p53 and Wdr5 double-knockout (DKO) EBs showed reduced expression of p53 direct target genes Cdkn1a and Bax ( Figures 6C and S6C ). While p53 deletion rescued cell proliferation defects in Wdr5 KO EBs at EB day 4 ( Figure 5A ), neither Rx + NE nor cardiogenic MES arose from DKO EBs ( Figure 5B ; data not shown), suggesting that p53 harbors proliferation-independent effects on cell fate.
Next, we added Dox (WDR5 rescue) to DKO EBs at T12h or T36-48h, which allowed us to determine whether p53 regulates WDR5-driven NE versus MES fate choice. Similar to Wdr5 KO EBs, early void (Dox, T12h) in DKO EBs stimulated Rx + NE differentiation ( Figures 5B and 5D ; Videos S1, S3, and S5). Rx + NE induction was WDR5 dose dependent ( Figure 5C ). Notably, unlike Wdr5 KO EBs with an extended void, which induces cardiogenic MES differentiation ( Figure 5E ; Video S4), DKO EBs with extended voids (Dox, T36-48h) did not form cardiogenic MES ( Figure 5E ; Video S6). Instead, Rx + NE differentiation occurred ( Figures 5B, 5D , 5E, and S6D). Corroborating these findings, EB day 6 ATAC-seq analyses revealed that NE-specific, open, unique peaks (chromatin accessible regions) in WT EBs that had closed (reduced chromatin accessibility) in Wdr5 KO EBs with T48h Rescue were restored to an open state in DKO EBs ( Figure 5F ). Similarly, unique, opening peaks associated with MES specification in Wdr5 KO EBs with T48h Rescue had closed in DKO EBs ( Figure 5F ). Thus, p53 controls the cardiogenic MES versus Rx + NE fate choice in Wdr5 KO EBs.
WDR5 Regulates p53-Dependent Chromatin Accessibility, Histone Methylation, and Transcription during ESC Lineage Specification
Next, we wondered whether WDR5 and p53 regulate common target genes during ESC lineage specification. We compared EB day 2 ATAC-seq chromatin accessibility profiles of control (Wdr5 KO with T12h Rescue ), Wdr5 KO , and DKO EBs. p53 deletion reversed closed peaks observed in day 2 Wdr5 KO EBs (increased chromatin accessibility at regions of previously decreased accessibility) when compared to control ( Figure 6A ). Compared to the T12h Rescue group, opening peaks in Wdr5 KO EBs modestly reverted ("closed") upon p53 deletion ( Figure 6A ).
To determine whether the above changes in chromatin accessibility lead to transcriptional changes, RNA-seq was performed on day 2 WT, Wdr5 KO , or DKO EBs from two independent ESC lines. Among 736 downregulated genes in Wdr5 KO EBs, 63% (464) of the genes were rescued by p53 deletion in DKO EBs (Figures S6E, 6B , and 6C). Among these genes, Bcl2l14 is a direct p53 target gene and downregulation or mutation of genes including Fras1, Thy1, Meis1, and Vax2OS has been reported in NE defects including eye development, which is consistent with phenotypes observed later in day 6 Wdr5 KO EBs ( Figure 1B) . Among 440 upregulated genes in Wdr5 KO EBs, 60% (262) of the genes were rescued by p53 deletion in DKO EBs ( Figures 6B and S6E ). Among these genes, Cdkn1a is a known p53 target gene ( Figure 6C ) and Wnt3 is a p53 direct target that in ESCs promotes MES differentiation (Wang et al., 2017) . Genes essential for MES specification such as Li et al. Page 8 Cell Rep. Author manuscript; available in PMC 2020 February 16.
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Mesp2, Lefty1, Nodal, or Pitx2 were upregulated in Wdr5 KO EBs but were repressed by p53 deletion in DKO EBs. Interestingly, reduced H3K4me3 at WT WDR5-bound peaks in Wdr5 KO EBs was partially rescued by p53 deletion ( Figure 6D ). Thus, WDR5 regulates p53-dependent chromatin accessibility, H3K4me3, and transcription during ESC specification.
WDR5 Regulates p53 Protein Stability and Directly Interacts with p53 during ESC Specification
Next, we sought to explore the mechanism(s) by which WDR5 regulates p53. We found that Wdr5 extended void did not alter p53 transcripts ( Figure 7A ) Xie et al., 2017) . We noticed that ChIP-seq peaks representing WDR5 bound to RP genes were overrepresented ( Figures S4E and S7A ; data not shown). Downregulation of a subset of RP genes was confirmed by RNA-seq ( Figure S7B ). It is known that reduced RP gene transcription triggers defects in ribosome biogenesis, which upregulates p53 activity via MDM2 inhibition (RP-MDM2-p53 pathway) (Liu et al., 2016) . Wdr5 deletion (EB day 2) and an extended void (EB day 6) led to downregulation of WDR5-bound RP genes including Rpl5, Rpl24, and Rpl29 (Figures 7B, 7C , and S7A). These data suggest that p53 activation due to Wdr5 deletion can be, in part, due to perturbation of WDR5-bound, RP target genes.
While p53 transcripts during lineage specification of WT and Wdr5 KO EBs were comparable ( Figure 7A ), Wdr5 KO EBs harbored elevated p53 protein levels ( Figure 7D ). We treated WT and Wdr5 KO EBs with the protein translation inhibitor cycloheximide (CHX), which showed that p53 stability was enhanced in Wdr5 KO EBs ( Figure 7D ). How does WDR5 regulate p53 stability? Post-translational modifications (PTMs) such as serine (S), phosphorylation (p), and lysine (K) acetylation (Ac) stabilize p53 (Hafner et al., 2019) . Indeed, we found that Wdr5 deletion in Wdr5 KO EBs increased p53 PTMs at p-p53 S15 , p-p53 S392 , Ac-p53 K305 , and Ac-p53 K379 ; WDR5 rescue reduced these PTMs ( Figure S7C ). Moreover, using immunofluorescence, we observed that prolonged deletion of Wdr5 led to increased nuclear p53 ( Figures S7D and S7E ). Together, Wdr5 deletion triggers PTMs that stabilize p53 and increase nuclear p53 activity, as evidenced by enhanced p53 stability and increased transcription of p53 direct target genes ( Figure 6C ).
Finally, by immunoprecipitation, we found that endogenous WDR5 and p53 physically interact during ESC specification ( Figure 7E ). We performed p53 CUT&RUN at EB day 2 and integrated the data with that of WDR5 CUT&RUN at EB day 2 ( Figure 7F ). We found co-recruitment of WDR5 and p53 to Rap2b, Irf2bp2, and Sox2 ( Figure 7G ). qRT-PCR confirmed that these direct, joint target genes displayed differential mRNA expression in WT and Wdr5 KO EBs, and that p53 deletion partially rescued defective transcription of these genes in Wdr5 KO EBs (Figures 7H and S7F) . Notably, Rap2b and Irf2bp2 are known direct targets of p53; these genes regulate cell proliferation (Zhang et al., 2013; Koeppel et al., 2009 ). p53 CUT&RUN of WT EBs at day 2 revealed that p53-bound motifs at target loci are shared with motifs bound by pro-MES TF NKX2.5 (data not shown). Thus, WDR5 directly interacts with p53 and regulates p53 activity via direct and indirect PTMs during ESC specification.
DISCUSSION
Transcription factors expressed at a particular time and location, and at proper magnitude during development, have traditionally been the focus of studies of cell fate determination.
In contrast, our study, using an ESC-to-organoid platform, unmasks time-dependent roles for the ubiquitous epigenetic protein and TF, WDR5 and p53, respectively, to control ESC fate choice.
Several WDR5-driven mechanisms regulate ESC differentiation. First, specific interaction sites that mediate WDR5-RbBP5 binding are required for NE differentiation. Second, WDR5 regulates p53 stability. WDR5 targets and transcriptionally activates a subset of RP genes. Wdr5 deletion leads to reduced transcription of these RP genes, triggering p53 activation via RP-MDM2-p53 pathway and to PTMs that increase p53 stability. Indeed, while this work was under review, a report independently confirmed our findings, which showed that RP genes are direct WDR5 targets and that WDR5 inhibition triggers p53 upregulation via the RP-MDM2-p53 pathway in leukemia cells (Aho et al., 2019 Given that RbBP5, MYC, or KANSL2 bind to the same WDR5 interaction surface in mutually exclusive manner, a central role for this binding surface on WDR5 on the regulation of NE fate is supported from RbBP5 and MYC loss-of-function assays from our study and others . RbBP5 depletion in ESCs leads to NE differentiation defects and deletion of c/n-Myc inhibits NE fates from mESCs (Jiang et al., 2011; Smith et al., 2010) . Since we observed enrichment of MYC-associated DNA motifs at WDR5 direct targets in NE-lineage cells at EB day 6, the interplay of WDR5, RbBP5, and MYC on chromatin to regulate NE lineage-identity genes warrants further study. p53 family members have been shown to regulate NE versus MES cell fate choice during development. In Xenopus, p53 promotes MES via an interaction with XFDL156, which represses ectoderm formation . In mESCs, p53/p63/p73 contribute to MES differentiation by integration of WNT-TCF and Nodal-SMAD signaling (Wang et al., 2017) . Indeed, we show that during prolonged Wdr5 inhibition, p53 deletion partially rescues Rx + NE fate and inhibits cardiogenic MES differentiation. In the context of WDR5dependent regulation, p63 and p73 do not appear to share redundant functions with p53, as p53 deletion alone is sufficient to stimulate NE and repress MES. Interestingly, p53associated human syndromes and analogous mouse models feature p53 hyperactivation and NE defects Van Nostrand et al., 2014) . Importantly, many of the p53-dependent, embryonic NE defects can be partially rescued by Li et 
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Author Manuscript p53 deletion, similar to our work Van Nostrand et al., 2014) . Still, whether our ESC-based study on the WDR5-p53 cell fate pathway relates to altered developmental events in vivo remains unknown.
Several pieces of evidence suggest that an instructive mechanism contributes to the WDR5-p53 cell fate pathway during lineage specification. First, Wdr5 deletion during a narrow time window (36-48 h after ESC exit from pluripotency) stimulates cardiogenic MES induction, highlighting that a short, 12-h "pulse" of Wdr5 inhibition initiates MES differentiation. Second, cell proliferation rates did not significantly differ in WT WDR5, Wdr5 KO (Wang et al., 2017) . Further, we found that WDR5 directly binds the MES master regulator Nodal, and that Nodal is rapidly derepressed within 36-48 h of Wdr5 loss during ESC specification. These findings further support an instructive role for WDR5-mediated cardiogenic MES induction (Kitajima et al., 2000) .
Here, we define a physical interaction between WDR5 and p53 and find that they jointly bind and regulate common target genes related to cell proliferation (Rap2b and Irf2bp2) and NE fate (Sox2). Whether co-recruitment of WDR5 and p53 "draws" these directly interacting proteins away from other known canonical or non-canonical partners with which WDR5 and p53 interact individually, allowing for transcription of NE genes and suppression of non-NE genes, is a concept that ought to be explored in future studies. Further, it will be important to determine the function of WDR5-p53 protein-protein interaction in p53associated human syndromes that feature congenital NE defects Van Nostrand et al., 2014; . Finally, our work informs future translational studies that investigate potential off-target/teratogenic effects of WDR5 inhibitors used for WT and mutant p53-associated cancers, a field that has attracted a $1 billion investment by industry (AP, 2019).
from RIKEN Cell Bank (Ibaraki, Japan) . Rx:GFP ESCs were maintained in leukemia inhibitory factor (LIF, ESG1107, Millipore) containing ES media [GMEM supplemented with 2.5 glutamine (GIBCO), 10% knockout serum replacement, KSR (GIBCO), 1% ES qualified fetal calf serum (FCS), 1 mM sodium pyruvate (Sigma), 0.1 mM non-essential amino acid (Sigma) and 0.1 mM of 2-mercaptoethnal (Sigma)].
METHOD DETAILS
ESC Maintenance and Induced Differentiation-Rx:GFP ESCs were routinely maintained at 37°C, 5% CO2 in ESC media in the presence of 2,000 IU/ml LIF. Induced differentiation to Rax (+) neuroectoderm via 3D (serum-free culture of embryoid-body-like aggregate with quick reaggregation, SFEBq) organoid methods was following a protocol as described previously. Briefly, 5,000 cells were re-suspended in 100 μl of GMEM based differentiation media supplemented with 5% KSR, 1 mM sodium pyruvate, 0.1 mM nonessential amino acid and 0.1 mM of 2-mercaptoethnal and 0.1 μM of retinoic acid receptor antagonist AGN 193109 Sodium Salt (AGN, Santa Cruz) and seeded on each well of 96U ultralow attachment plate (ThermoFisher Scientific) on day 0. On day 1, 50 μl of 2% Matrigel solution (v/v, Corning) was added to embryonic body (EB) suspension. NE differentiation was sustained in 96U plate for 6 to 9 days and differentiation efficiency was monitored by GFP via fluorescent microscopy (OLYPUS IX73) and flow cytometry (BD LSR II). For differentiation of ESCs using SFEBq method without matrigel and AGN, 5,000 cells were re-suspended in 150 μl of GMEM based differentiation media with 10% KSR as described elsewhere (Kamiya et al., 2011) . For secondary hematopoietic cell differentiation, day 6 or 9 SFEBq organoids were re-suspended and trypsinized to single cell suspension. 1×10 5 cells were seeded to methylcellulose based semisolid media M3234 (Stem Cell Technologies) in the presence of IL-3 (10ng/ml), SCF (10ng/ml) and GM-CSF (10ng/ml). After 9 days of differentiation, resultant colony forming units (CFU) were counted under microscope (OLYPUS IX73). For NE differentiation under adherent monolayer condition, we followed a protocol as described elsewhere (Ying et al., 2003) . RNA Isolation, Reverse Transcription, and Quantitative Real-Time PCR (RT-qPCR)-Trizol reagent (ThermoFisher Scientific) and RNeasy mini kit (QIAGEN) were utilized for RNA isolation from ESCs or EBs. 1.0 μg total RNA was reversely transcribed to cDNA using high-capacity RNA-to-cDNA kit (ThermoFisher Scientific). RT-qPCR was performed using iQ SYBR green supermix (Bio-Rad). Gapdh, β-actin was used as internal control for normalization. Primer sequences for real-time PCR were available upon request. Data were automatically analyzed using Bio-Rad CFX manager software using ΔΔCt method.
Plasmids and ESC Transfection-Plasmids

Whole-Cell Lysate Preparation, Histone Extraction, Western Blotting, and
Immunoprecipitation-ESCs or EBs were lysed with RIPA buffer (Pierce) in the presence of EDTA free protease inhibitor cocktail (Sigma). Histone extraction on EBs was performed using a histone extraction kit (Abcam) as described previously (Khan et al., 2015) . Protein concentration was determined using Pierce BCA protein assay kit (ThermoFisher Scientific). 1.0 μg of histone extracts, or 10 μg of whole cell lysate was resolved on 4%-20% precast gel (Bio-Rad) was transferred to 0.45 μm PVDF membrane (Millipore). For immunoprecipitation, day 2 WT and Wdr5 KO EBs were harvested and lysed in RIPA buffer with EDTA free protease inhibitor cocktail (Sigma). 1 mg sonicated cell lysates were subjected to immunoprecipitation using WDR5 antibody (Bethyl). The following primary antibodies were used for probing: anti-HA (1:10,000, Abcam, ab9110), anti-WDR5 (1:5000, R&D), anti-WDR5 (1:5,000, Bethyl), anti-Flag (1:2,000, Sigma), anti-H3 (1:10,000, Abcam), anti-H3K4Me1 (1:5,000, Millipore), anti-H3K4Me2 (1:10,000, Millipore), anti-H3K4Me3 (1:10,000, Abcam), anti-P53 (1:5,000, Cell Signaling), anti-Tubulin (1:10,000, Cell signaling), anti-β-Actin (1:10,000, Cell signaling), anti-Phospho-p53 (Ser15) Antibody (1:5,000, Cell Signaling), anti-Phospho-p53 (Ser392) Antibody (1:5,000, Abcam), anti-Acetyl-p53 (K305) Antibody (1:5,000, Abcam), anti-Actyl-p53 (K379) Antibody (1:5,000, Cell Signaling).
Immunohistochemistry, Cytospin, and Immunofluorescence Staining-Day 9 EBs were harvested and fixed with 4% paraformaldehyde at 4°C overnight. EBs were sent to ULAM (Unit for laboratory animal medicine) at University of Michigan for paraffin processing, embedding, and sectioning. Antigen unmasking on slides was using citric acid methods as prescribed previously (Gage and Camper, 1997) . Immunostaining was performed by combining of VectaStain ABC-HRP kit (Vector laboratories) and TSA Kit #24, with HRP-Streptavidin and Alexa Fluor 568 Tyramide (ThermoFisher Scientific). The primary antibodies were used for staining: anti-N-cadherin (mouse/ monoclonal/1:2000, BD) , anticardiac troponin T (CT3 clone, mouse/monoclonal/1:100, Developmental Studies Hybridoma Bank) and anti-myosin heavy chain antibody (MF20 clone, mouse/monoclonal/ 1:100, Developmental Studies Hybridoma Bank). For cytospin, Day 2 WT and Wdr5 KO EBs were harvested and trypsinized to single cell suspension. Cells were attached to EZ cytofunnels (ThermoFisher) slides using Cytospin 3 (Shandon). Cells were fixed with 100% methanol and immunostaining was performed using p53 antibody (NCL-L-P53-CM5P, Leica biosystems) at 1:100 dilution. Counter nuclear staining was performed with DAPI (Molecular Probes). Control sections were incubated without primary antibodies. 4 representative pictures from different field were recorded under fluorescence microscope (Olympus DP73).
Flow Cytometry-2 to 4 EBs (organoids) were combined and dissociated to single cell suspension by 0.25% trypsin-EDTA (Invitrogen). DMEM media with 10% FBS (Sigma, v/v) was used to inactivate trypsin and cells were subjected to spin down at 300 g for 5 min. Cell pellet was washing once using D-PBS without calcium and magnesium and re-suspended in 200 μl of D-PBS in V-bottom plate. Cells were immediately transferred to LSR-II flowcytometer (BD) for data recording and analysis. The dead cells in the cell population were gated out and percentage of GFP (+) cells were calculated on live cells.
ATAC-Seq-Time-course ATAC-Seq on SFEBq organoids with duplicates at day 2, 4 and 6 were performed using Nextera DNA sample prep kit (Illumina) by following a protocol described elsewhere. 5×10 4 cells were washed with cold D-PBS and resuspended in 50 μl of cold lysis buffer (CHP-118-C, Boston Bioproducts) and pelleted. Transposition reaction by Tn5 transposase was incubated in TD buffer at 37°C for 30 min. After purification with MinElute Kit (QIAGEN), transposed DNA fragments were amplified through PCR using bar-coded Nextera PCR primers. Extra number of PCR cycles were added by qPCR as described and amplified DNA products were subjected to another round of DNA purification using MinElute Kit. Libraries were sent to University of Michigan DNA Sequencing Core for quality control test based on Bioanalyzer and sequenced using HiSeq 2500 or 4000 with pair-end reads. (Skene and Henikoff, 2017; Skene et al., 2018) and the following antibodies were used: WDR5 antibody (Bethyl), P53 antibody (NCL-L-P53-CM5P, Leica biosystems) and H3K4me3 antibody (Abcam). Protein A-micrococcal nuclease (pA-MN) fusion protein were generously provided by Dr. Steven Henikoff.
RNA-Seq
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical Analysis-All experiments were independently repeated with different mWdr5 KO ESC clones at least for 2 to 4 times with similar results, and data from one representative experiment are presented unless otherwise stated. Two-tailed unpaired Student's t test was applied using GraphPad Prism (version 7.00) to determine whether the observed differences were statistically significant. Changes were considered statistically significant when p value less than 0.05.
Bioinformatics Analysis
Reads Mapping and Coverage: All RNA-seq data were mapped to the mm10 genome for mouse, and hg38 genome for human, using Tophat2 (2.1.1) (Kim et al., 2013) , which was shown to be accurate alignment of transcriptomes in the presence of insertions, deletions, and gene fusions. Then, duplicated reads for pair-end data were removed, but not single-end data by SAMtools (v1.5) (Li et al., 2009 ). All ChIP-seq, ATAC-seq, and CUT&RUN sequencing data were mapped to the mm10 genome for mouse by using Bowtie2 (v2-2.2.4) with parameters "-q-phred33-very-sensitive -p 10" (Langmead and Salzberg, 2012) , which is ultrafast and memory-efficient tool for aligning sequencing reads to long reference sequences. Then, we removed any duplicated reads for both pair-end and single-end data using SAMtools (v1.5) (Li et al., 2009) . For all sequencing datasets, the bigwig files for visualization in Integrative Genomics Viewer (IGV) (Thorvaldsdóttir et al., 2013) were generated from BAM files by using "bamCoverage" from deepTools (Ramírez et al., 2014) with parameters "-ignoreDuplicates-normalizeUsingRPKM-skipNonCoveredRegions-binSize 50." The bigwig files for IP/input ratio were generated from BAM files by using deepTools2 (v2.5.0) (Ramírez et al., 2016) with command "bamCompare -b1 ChIP-bam -b2 Input-bam-ignoreDuplicates-minMappingQuality 30-normalizeUsing RPKM -binSize 20operation ratio-scaleFactorsMethod None -p 20." Whereas, for ATAC-seq and CUT&RUN datasets, the bigwig files were generated from BAM files by using deepTools2 (v2.5.0) (Ramírez et al., 2016) with command "bamCoverage-outFileFormat bigwig-ignoreForNormalization chrM chrX chrY-skip-NAs-bam bowtie2.rmdup.bam-outFileName output.bigwig-normalizeUsing RPKM-minMappingQuality 30-binSize 20-smooth-Length 60-ignoreDuplicates-scaleFactor 1-numberOfProcessors 2."BAM files of mapping results were merged for the same sample using SAMtools and converted to BED format by using BEDTools (Quinlan and Hall, 2010) . Peaks of regulatory regions were called for each sample by using MACS (v 1.4.2) (Zhang et al., 2008) from bed files of ChIP-seq with parameters "-w -S -p 0.00001 -g mm." The input signal was used as the control to call peaks for the ChIP-seq dataset. The heatmap plot of signals centered on peaks was implicated by deepTools2. The heatmap plot of signals centered on peaks was implicated by deepTools2 subcommand plotHeatmap.
Peak Calling and Annotation: BAM files of mapping results were merged for the same sample using SAMtools and converted to BED format by using BEDTools (Quinlan and Hall, 2010) . Peaks of regulatory regions were called for each sample by using MACS (v 1.4.2) (Zhang et al., 2008) from datasets of ChIP-seq with parameters "-w -S -p 0.00001."
The input signal was used as the control to call peaks for the ChIP-seq dataset. The heatmap plot of signals centered on peaks and gene promoters was implicated by deepTools2 (v2.5.0) (Ramírez et al., 2016) . Peak annotation was performed by using HOMER (v4.9.1) (Heinz et al., 2010) with default parameters. Motif analysis on peak regions was performed with HOMER function findMotifsGenome.pl with parameters "-size 50 -mask." (C) Immunofluorescence staining on day 9 EB sections with neuroepithelial marker (Ncadherin), cardiac specific troponin T (CT3), and sarcomere myosin (MF20) in WT, early Figure S4 . Samples were analyzed at EB day 6. 
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